Literature DB >> 7902420

Amino acid neurotransmitters in nucleus tractus solitarius: an in vivo microdialysis study.

A F Sved1, J T Curtis.   

Abstract

Amino acid neurotransmitters in the nucleus tractus solitarius (NTS) are thought to play a key role in the mediation of visceral reflexes and glutamate has been proposed as the neurotransmitter of visceral afferent nerves projecting to this region. The present studies sought to characterize the use of in vivo microdialysis to examine extracellular fluid levels of amino acids in the NTS of anesthetized rats. Using a microdialysis probe that was 450 microns in length and a sensitive HPLC assay for amino acids, amino acids could be measured in dialysate samples collected from the NTS. Perfusion of the microdialysis probe with 60 mM K+, to elicit depolarization of nerve terminals in the vicinity of the probe, resulted in increased dialysate fluid levels of aspartate, glutamate, glycine, taurine, and GABA. In contrast, glutamine and tyrosine were decreased and other amino acids were not significantly affected. Prior removal of the ipsilateral nodose ganglion did not alter the K(+)-evoked changes in dialysate levels of any of these amino acids. Electrical stimulation of the vagus nerves, using a variety of stimulus parameters, did not significantly alter dialysate levels of glutamate or any of the other amino acids that were measured. Blockade of glutamate uptake with dihydrokainate increased dialysate levels of glutamate, aspartate, and GABA, but in the presence of dihydrokainate vagal stimulation did not alter dialysate levels of these amino acids. The results show that in vivo microdialysis can be used to examine amino acid efflux in the rat NTS and provide further evidence for amino acidergic neural transmission in the NTS. However, these studies fail to support the hypothesis that vagal afferents release glutamate or aspartate.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902420     DOI: 10.1111/j.1471-4159.1993.tb07446.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Social bonding decreases the rewarding properties of amphetamine through a dopamine D1 receptor-mediated mechanism.

Authors:  Yan Liu; Kimberly A Young; J Thomas Curtis; Brandon J Aragona; Zuoxin Wang
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  GABA(A) receptor epsilon-subunit may confer benzodiazepine insensitivity to the caudal aspect of the nucleus tractus solitarii of the rat.

Authors:  S Kasparov; K A Davies; U A Patel; P Boscan; M Garret; J F Paton
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

3.  Effects of 4-aminopyridine on extracellular concentrations of glutamate in striatum of the freely moving rat.

Authors:  G Segovia; A Porras; F Mora
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

Review 4.  Putative roles of neuropeptides in vagal afferent signaling.

Authors:  Guillaume de Lartigue
Journal:  Physiol Behav       Date:  2014-03-18

5.  Neurochemical Mediation of Affiliation and Aggression Associated With Pair-Bonding.

Authors:  Kyle L Gobrogge; Xixi Jia; Yan Liu; Zuoxin Wang
Journal:  Biol Psychiatry       Date:  2016-02-21       Impact factor: 13.382

6.  Amphetamine effects in microtine rodents: a comparative study using monogamous and promiscuous vole species.

Authors:  J T Curtis; Z Wang
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

7.  Oxytocin reverses amphetamine-induced deficits in social bonding: evidence for an interaction with nucleus accumbens dopamine.

Authors:  Kimberly A Young; Yan Liu; Kyle L Gobrogge; Hui Wang; Zuoxin Wang
Journal:  J Neurosci       Date:  2014-06-18       Impact factor: 6.167

Review 8.  Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects.

Authors:  Marina V Basalay; Sean M Davidson; Andrey V Gourine; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2018-06-01       Impact factor: 17.165

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.